应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
IQV 艾昆纬
已收盘 05-10 16:00:00 EDT
234.08
+4.88
+2.13%
盘后
234.30
+0.22
+0.09%
17:35 EDT
最高
234.74
最低
230.06
成交量
126.19万
今开
230.92
昨收
229.20
日振幅
2.04%
总市值
426.49亿
流通市值
422.50亿
总股本
1.82亿
成交额
2.94亿
换手率
0.70%
流通股本
1.80亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
艾昆纬2024财年第一财季实现净利润2.88亿美元,同比减少0.35%
自选股智能写手 · 00:18
艾昆纬2024财年第一财季实现净利润2.88亿美元,同比减少0.35%
Baird:维持IQVIA Hldgs(IQV.US)评级,由中性调整至中性评级, 目标价由254.00美元调整至245.00美元。
智通财经 · 05-03
Baird:维持IQVIA Hldgs(IQV.US)评级,由中性调整至中性评级, 目标价由254.00美元调整至245.00美元。
美元走强,IQVIA 下调全年收入预期
Reuters · 05-03
美元走强,IQVIA 下调全年收入预期
IQVIA Holdings Inc 预计每股收益2.48美元 - 财报前瞻
Reuters · 04-30
IQVIA Holdings Inc 预计每股收益2.48美元 - 财报前瞻
艾昆纬医药科技(上海)有限公司申请II类会议
金融界 · 04-11
艾昆纬医药科技(上海)有限公司申请II类会议
礼来减肥药 Zepbound 在美国的新处方首次超过威戈维
Reuters · 03-16
礼来减肥药 Zepbound 在美国的新处方首次超过威戈维
艾昆纬盘中异动 早盘股价大涨5.00%
自选股智能写手 · 02-22
艾昆纬盘中异动 早盘股价大涨5.00%
艾昆纬2023财年实现净利润13.58亿美元,同比增加24.47%
自选股智能写手 · 02-18
艾昆纬2023财年实现净利润13.58亿美元,同比增加24.47%
嗡嗡声--美国股票走势-CME Group、Robinhood Markets、花旗集团
Reuters · 02-15
嗡嗡声--美国股票走势-CME Group、Robinhood Markets、花旗集团
艾昆纬盘中异动 早盘股价大涨6.94%
自选股智能写手 · 02-14
艾昆纬盘中异动 早盘股价大涨6.94%
BUZZ-IQVIA 在第四季度业绩超预期后攀升
Reuters · 02-14
BUZZ-IQVIA 在第四季度业绩超预期后攀升
IQVIA Holdings Inc 预计每股收益2.82美元 - 财报前瞻
Reuters · 02-12
IQVIA Holdings Inc 预计每股收益2.82美元 - 财报前瞻
艾昆纬涨3.32% 股价突破200美元大关
自选股智能写手 · 2023-11-14
艾昆纬涨3.32% 股价突破200美元大关
加载更多
公司概况
公司名称:
艾昆纬
所属市场:
NYSE
上市日期:
--
主营业务:
IQVIA Holdings Inc.是世界上最大的生物制药研发服务和商业外包服务最大的提供商。公司定位于商业服务和医疗保健服务的结合,并在2014年产生了42亿美元的营业额。公司在大约100个国家开展业务,同时拥有将近86,000名员工。公司利用所提供服务的广度和深度、遍布全球的足迹以及在疗法、科学以及分析学方面的专业技能帮助公司的生物制药客户,以及其它医疗保健客户,让他们在愈加复杂多变的医疗保健领域更加成功。公司1982年由Gillings博士创建成立,他是位于教堂山的北卡罗莱纳大学的生物统计学博士。
发行价格:
--
{"stockData":{"symbol":"IQV","market":"US","secType":"STK","nameCN":"艾昆纬","latestPrice":234.08,"timestamp":1715371200000,"preClose":229.2,"halted":0,"volume":1261897,"hourTrading":{"tag":"盘后","latestPrice":234.3,"preClose":234.08,"latestTime":"17:35 EDT","volume":18568,"amount":4346417.31,"timestamp":1715376930506},"delay":0,"floatShares":180493970,"shares":182200000,"eps":7.32664,"marketStatus":"已收盘","marketStatusCode":5,"change":4.88,"latestTime":"05-10 16:00:00 EDT","open":230.92,"high":234.735,"low":230.055,"amount":294025710.97718,"amplitude":0.020419,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":7.32664,"exchange":"NYSE","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1715587200000},"adr":0,"listingDate":1368072000000,"adjPreClose":229.2,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":230,"preClose":229.2,"latestTime":"08:00 EDT","volume":10,"amount":2300,"timestamp":1715342400171},"postHourTrading":{"tag":"盘后","latestPrice":234.3,"preClose":234.08,"latestTime":"17:35 EDT","volume":18568,"amount":4346417.31,"timestamp":1715376930506},"volumeRatio":1.655597},"requestUrl":"/m/hq/s/IQV/","defaultTab":"news","newsList":[{"id":"2434786950","title":"艾昆纬2024财年第一财季实现净利润2.88亿美元,同比减少0.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434786950","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434786950?lang=zh_cn&edition=full","pubTime":"2024-05-11 00:18","pubTimestamp":1715357923,"startTime":"0","endTime":"0","summary":"3月31日,艾昆纬公布财报,公告显示公司2024财年第一财季净利润为2.88亿美元,同比减少0.35%;其中营业收入为37.40亿美元,同比增加2.89%,每股基本收益为1.58美元。从资产负债表来看,艾昆纬总负债202.30亿美元,其中短期债务7.17亿美元,资产负债比为1.32,流动比率为0.88。机构评级:截至2024年3月31日,当前有19家机构对艾昆纬目标价做出预测,其中目标均价为270.02美元,其中最低目标价为235.00美元,最高目标价为295.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405110018478af1a773&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405110018478af1a773&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432920539","title":"Baird:维持IQVIA Hldgs(IQV.US)评级,由中性调整至中性评级, 目标价由254.00美元调整至245.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2432920539","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2432920539?lang=zh_cn&edition=full","pubTime":"2024-05-03 19:05","pubTimestamp":1714734354,"startTime":"0","endTime":"0","summary":"Baird:维持IQVIA Hldgs(IQV.US)评级,由中性调整至中性评级, 目标价由254.00美元调整至245.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405031905598b702f7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405031905598b702f7a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432778981","title":"美元走强,IQVIA 下调全年收入预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2432778981","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432778981?lang=zh_cn&edition=full","pubTime":"2024-05-03 00:07","pubTimestamp":1714666069,"startTime":"0","endTime":"0","summary":" 路透5月2日 - 受美元走强影响,合同研究公司IQVIA Holdings 周四下调了全年营收预期,并公布了一项备受关注的指标的季度环比跌幅,导致股价下跌近4%。第一季度,IQVIA 的调整后每股利润为 2.54 美元,超过了伦敦证券交易所集团预计的 2.48 美元,这主要得益于其最大部门研发解决方案部门的强劲销售,该部门为生物制药公司提供合同研究设施。R&DS 部门的收入增长了 3.4%,达到 21 亿美元,高于预期的 20.6 亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2431376170","title":"IQVIA Holdings Inc 预计每股收益2.48美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2431376170","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2431376170?lang=zh_cn&edition=full","pubTime":"2024-04-30 23:27","pubTimestamp":1714490873,"startTime":"0","endTime":"0","summary":"* LSEG 的分析师平均预期 IQVIA 控股公司的每股收益为 2.48 美元。该公司 2024 年 2 月 14 日发布的截至 3 月 31 日的每股收益指导值为 2.45 美元至 2.55 美元。* 华尔街对 IQVIA Holdings Inc 的 12 个月目标价中位数为 277.00 美元,高于其最新收盘价 235.48 美元。4月30日 - 该公司2024年2月14日发布的截至3月31日的业绩指引是,未计利息、税项、折旧及摊销前的利润为36.5亿美元至8.7亿美元。除非另有说明,所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2426647251","title":"艾昆纬医药科技(上海)有限公司申请II类会议","url":"https://stock-news.laohu8.com/highlight/detail?id=2426647251","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2426647251?lang=zh_cn&edition=full","pubTime":"2024-04-11 20:15","pubTimestamp":1712837724,"startTime":"0","endTime":"0","summary":"金融界4月11日消息,据CDE官网沟通交流公示,于4月11日收到艾昆纬医药科技(上海)有限公司申请的“II类会议”,当前状态“处理中”。根据《药物研发与技术审评沟通交流管理办法》(2020年第48号通告),沟通交流会议分为Ⅰ类、Ⅱ类和Ⅲ类会议,就关键阶段重大问题进行沟通交流。Ⅱ类会议一般安排在申请后60日内召开,系指为药物在研发关键阶段而召开的会议,主要包括下列情形:新药临床试验申请前会议、药物Ⅱ期临床试验结束/Ⅲ期临床试验启动前会议、新药上市许可申请前会议、风险评估和控制会议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041120152887679e07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041120152887679e07&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419618895","title":"礼来减肥药 Zepbound 在美国的新处方首次超过威戈维","url":"https://stock-news.laohu8.com/highlight/detail?id=2419618895","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2419618895?lang=zh_cn&edition=full","pubTime":"2024-03-16 01:38","pubTimestamp":1710524330,"startTime":"0","endTime":"0","summary":" Patrick Wingrove 路透社3月15日 - 根据IQVIA的数据,礼来 的强效减肥药Zepbound在截至3月8日的一周内新增处方77590张,自上市以来首次超过了诺和诺德 的竞争对手肥胖药Wegovy。据 GlobalData 预测,到 2029 年,礼来的糖尿病药物 Mounjaro将成为最畅销的 GLP-1 药物,年销售额将达到 334 亿美元。礼来公司本周表示,它已与亚马逊公司 的药房部门合作,向其直接面向消费者的服务LillyDirect发送药品处方 ,其中包括Zepbound的处方。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2413100932","title":"艾昆纬盘中异动 早盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2413100932","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413100932?lang=zh_cn&edition=full","pubTime":"2024-02-22 23:36","pubTimestamp":1708616173,"startTime":"0","endTime":"0","summary":"北京时间2024年02月22日23时36分,艾昆纬股票出现异动,股价急速拉升5.00%。截至发稿,该股报249.16美元/股,成交量59.8001万股,换手率0.33%,振幅4.43%。艾昆纬股票所在的生命科学行业中,整体涨幅为1.09%。其相关个股中,Icon Plc、Psychemedics Corp、Xwell Inc涨幅较大,Icon Plc、23Andme Holding Co、精密科学较为活跃,换手率分别为0.65%、0.59%、0.58%,振幅较大的相关个股有Ispecimen Inc、Psychemedics Corp、Icon Plc,振幅分别为10.44%、9.47%、8.83%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022223361487e7249c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022223361487e7249c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2412601507","title":"艾昆纬2023财年实现净利润13.58亿美元,同比增加24.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2412601507","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2412601507?lang=zh_cn&edition=full","pubTime":"2024-02-18 00:20","pubTimestamp":1708186819,"startTime":"0","endTime":"0","summary":"12月31日,艾昆纬公布财报,公告显示公司2023财年净利润为13.58亿美元,同比增加24.47%;其中营业收入为150.05亿美元,同比增加4.06%,每股基本收益为7.39美元。从资产负债表来看,艾昆纬总负债205.69亿美元,其中短期债务8.25亿美元,资产负债比为1.30,流动比率为0.87。机构评级:截至2023年12月31日,当前有18家机构对艾昆纬目标价做出预测,其中目标均价为266.44美元,其中最低目标价为235.00美元,最高目标价为300.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021800202881963093&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021800202881963093&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411586576","title":"嗡嗡声--美国股票走势-CME Group、Robinhood Markets、花旗集团","url":"https://stock-news.laohu8.com/highlight/detail?id=2411586576","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2411586576?lang=zh_cn&edition=full","pubTime":"2024-02-15 00:22","pubTimestamp":1707927752,"startTime":"0","endTime":"0","summary":" * 个股异动的 Eikon 搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 2月14日 - 周三,华尔街在上一交易日因通胀报告火爆而遭遇抛售后获得了一些动力,而 Nvidia 的市值则超过了 Alphabet,成为美国市值第三高的公司。美东时间10:44,道琼斯工业平均指数 上涨0.21%,报38352.84点。标准普尔500指数 上涨0.56%,报4,981.12点;纳斯达克综合指数 上涨0.73%,报15,770.342点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2411077533","title":"艾昆纬盘中异动 早盘股价大涨6.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2411077533","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2411077533?lang=zh_cn&edition=full","pubTime":"2024-02-14 22:34","pubTimestamp":1707921249,"startTime":"0","endTime":"0","summary":"北京时间2024年02月14日22时34分,艾昆纬股票出现波动,股价大幅拉升6.94%。截至发稿,该股报230.22美元/股,成交量9.6128万股,换手率0.05%,振幅1.41%。艾昆纬股票所在的生命科学行业中,整体涨幅为0.96%。其相关个股中,福纳、Personalis Inc、艾昆纬涨幅较大,Endra Life Sciences Inc、T2 Biosystems Inc、福纳较为活跃,换手率分别为1.13%、0.19%、0.18%,振幅较大的相关个股有Ispecimen Inc、Personalis Inc、福纳,振幅分别为6.54%、4.95%、4.89%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240214223409879063d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240214223409879063d9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411897306","title":"BUZZ-IQVIA 在第四季度业绩超预期后攀升","url":"https://stock-news.laohu8.com/highlight/detail?id=2411897306","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2411897306?lang=zh_cn&edition=full","pubTime":"2024-02-14 21:14","pubTimestamp":1707916470,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 2月14日 - ** 合同研究公司IQVIA Holdings 股价盘前上涨约3%至222美元** 公司报告 (link) 第四季度利润为每小时 2.84 美元,高于分析师平均预期的每小时 2.82 美元 - LSEG 数据** IQV 季度收入 38.7 亿美元,高于分析师平均预期的 38.0 亿美元。** 该公司预测2024年每股收益在10.95美元至11.25美元之间,中间值高于分析师平均预期的每股收益11.07美元。 ** 截至上次收盘,过去 12 个月股价下跌 7.3","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2410840329","title":"IQVIA Holdings Inc 预计每股收益2.82美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2410840329","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2410840329?lang=zh_cn&edition=full","pubTime":"2024-02-12 22:19","pubTimestamp":1707747547,"startTime":"0","endTime":"0","summary":" * LSEG 的分析师平均预计 IQVIA 控股公司的每股收益为 2.82 美元。该公司在 2023 年 11 月 1 日发布的截至 12 月 31 日的每股收益指导介于 2.79 美元和 2.86 美元之间。* 华尔街对 IQVIA Holdings Inc 的 12 个月目标价中位数为 243.50 美元,高于其上次收盘价 218.20 美元。2月12日 - 该公司在2023年11月1日发布的截至12月31日的业绩指引中,未计利息、税项、折旧及摊销前的利润为37.69亿美元至9.67亿美元。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2383023483","title":"艾昆纬涨3.32% 股价突破200美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2383023483","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2383023483?lang=zh_cn&edition=full","pubTime":"2023-11-14 23:05","pubTimestamp":1699974303,"startTime":"0","endTime":"0","summary":"北京时间2023年11月14日23时05分,艾昆纬股票出现波动,股价大幅上涨3.32%。截至发稿,该股报200.09美元/股,成交量7.3236万股,换手率0.04%,振幅1.40%。艾昆纬股票所在的生命科学行业中,整体涨幅为3.35%。艾昆纬公司简介:艾昆纬是全球领先的合同研究机构Quintiles与领先的医疗数据和分析提供商IMS Health在2016年合并的结果。消息层面,截至23时05分,艾昆纬股票正面舆情新闻比例100%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202311142305038304b6f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202311142305038304b6f2&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.iqvia.com","stockEarnings":[{"period":"1week","weight":0.0318},{"period":"1month","weight":-0.0657},{"period":"3month","weight":0.0504},{"period":"6month","weight":0.1695},{"period":"1year","weight":0.2186},{"period":"ytd","weight":-0.0094}],"compareEarnings":[{"period":"1week","weight":0.03},{"period":"1month","weight":0.0016},{"period":"3month","weight":0.0378},{"period":"6month","weight":0.1806},{"period":"1year","weight":0.2599},{"period":"ytd","weight":0.0944}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"IQVIA Holdings Inc.是世界上最大的生物制药研发服务和商业外包服务最大的提供商。公司定位于商业服务和医疗保健服务的结合,并在2014年产生了42亿美元的营业额。公司在大约100个国家开展业务,同时拥有将近86,000名员工。公司利用所提供服务的广度和深度、遍布全球的足迹以及在疗法、科学以及分析学方面的专业技能帮助公司的生物制药客户,以及其它医疗保健客户,让他们在愈加复杂多变的医疗保健领域更加成功。公司1982年由Gillings博士创建成立,他是位于教堂山的北卡罗莱纳大学的生物统计学博士。","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.001154},{"month":2,"riseRate":0.545455,"avgChangeRate":0.02674},{"month":3,"riseRate":0.636364,"avgChangeRate":-0.015596},{"month":4,"riseRate":0.363636,"avgChangeRate":0.02764},{"month":5,"riseRate":0.636364,"avgChangeRate":0.02308},{"month":6,"riseRate":0.727273,"avgChangeRate":0.031974},{"month":7,"riseRate":0.818182,"avgChangeRate":0.072158},{"month":8,"riseRate":0.454545,"avgChangeRate":-0.000639},{"month":9,"riseRate":0.272727,"avgChangeRate":-0.035653},{"month":10,"riseRate":0.363636,"avgChangeRate":-0.001708},{"month":11,"riseRate":0.727273,"avgChangeRate":0.039977},{"month":12,"riseRate":0.636364,"avgChangeRate":0.018846}],"exchange":"NYSE","name":"艾昆纬","nameEN":"IQVIA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"艾昆纬(IQV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供艾昆纬(IQV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"艾昆纬,IQV,艾昆纬股票,艾昆纬股票老虎,艾昆纬股票老虎国际,艾昆纬行情,艾昆纬股票行情,艾昆纬股价,艾昆纬股市,艾昆纬股票价格,艾昆纬股票交易,艾昆纬股票购买,艾昆纬股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"艾昆纬(IQV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供艾昆纬(IQV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}